Moreover, it was evaluated whether treatment with TSA can alleviate these effects, proposing a novel mechanism linking environmental and epigenetic factors in AD, and offering insights into HDAC-targeted therapies [3, 13, -15, 21, 22, 25]. The gene discussed is HDAC9; the disease is Alzheimer disease.